STOCK TITAN

Guardant Health (NASDAQ: GH) Form 144: 2,000 shares listed, 3,000 sold

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Guardant Health reports a Form 144 filing listing 2,000 shares to be sold. The filing names Charles Schwab & Co., Inc. as the broker and records a prior sale of 3,000 shares on 03/16/2026.

The shares are described as tied to a Performance Stock Lapse from 02/01/2025

Positive

  • None.

Negative

  • None.

Insights

Routine resale notice under Rule 144; no material corporate action disclosed.

The filing lists 2,000 shares available to sell and notes a prior sale of 3,000 shares on 03/16/2026. It names Charles Schwab & Co., Inc. as the broker and cites an equity compensation source.

These entries are administrative disclosures required for resale; cash‑flow treatment and pricing are not included in the excerpt. Subsequent filings would show consummated transactions or pricing details.

Shares listed to be sold 2,000 shares Securities To Be Sold; <date>02/01/2025</date>
Shares sold in past 3 months 3,000 shares Securities Sold During The Past 3 Months; <date>03/16/2026</date>
Broker Charles Schwab & Co., Inc. Broker listed for proposed sale; Westlake TX address
Form 144 regulatory
"Filer Information | | | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Performance Stock Lapse financial
"Common | 02/01/2025 | Performance Stock Lapse | GUARDANT HEALTH, INC."
Equity Compensation financial
"02/01/2025 | Equity Compensation"
Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Guardant Health's (GH) Form 144 report?

It reports a proposed sale listing 2,000 shares to be sold. The filing names Charles Schwab & Co., Inc. as the broker and ties the shares to a Performance Stock Lapse dated 02/01/2025.

Was there recent selling activity disclosed for GH insiders?

Yes, the excerpt records a prior sale of 3,000 shares on 03/16/2026. That transaction appears under "Securities Sold During The Past 3 Months." The filing does not provide sale price or proceeds information.

Who is the broker handling the proposed sale in the Form 144?

The broker listed is Charles Schwab & Co., Inc. at the Westlake, TX address. The filing shows the broker name and contact line but does not state execution timing or pricing details.